These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22560470)

  • 21. Oxazin-5-Ones as a Novel Class of Penicillin Binding Protein Inhibitors: Design, Synthesis and Structure Activity Relationship.
    Onoabedje EA; Ibezim A; Okafor SN; Onoabedje US; Okoro UC
    PLoS One; 2016; 11(10):e0163467. PubMed ID: 27749913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I.
    Srivastava SK; Dube D; Tewari N; Dwivedi N; Tripathi RP; Ramachandran R
    Nucleic Acids Res; 2005; 33(22):7090-101. PubMed ID: 16361267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
    Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
    J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.
    Meier TI; Yan D; Peery RB; McAllister KA; Zook C; Peng SB; Zhao G
    FEBS J; 2008 Nov; 275(21):5258-71. PubMed ID: 18795946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
    Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A
    ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases.
    Tomasić T; Zidar N; Kovac A; Turk S; Simcic M; Blanot D; Müller-Premru M; Filipic M; Grdadolnik SG; Zega A; Anderluh M; Gobec S; Kikelj D; Peterlin Masic L
    ChemMedChem; 2010 Feb; 5(2):286-95. PubMed ID: 20024979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
    Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
    J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterocyclic methylsulfone hydroxamic acid LpxC inhibitors as Gram-negative antibacterial agents.
    McAllister LA; Montgomery JI; Abramite JA; Reilly U; Brown MF; Chen JM; Barham RA; Che Y; Chung SW; Menard CA; Mitton-Fry M; Mullins LM; Noe MC; O'Donnell JP; Oliver RM; Penzien JB; Plummer M; Price LM; Shanmugasundaram V; Tomaras AP; Uccello DP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6832-8. PubMed ID: 23046961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and antibacterial activities of a series of new 2-oxaisocephems.
    Wu J; Wu X; Lei F; Yuan H; Hai L; Wu Y
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5293-6. PubMed ID: 22795329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: synthesis and preliminary SAR analysis.
    Gomez L; Hack MD; Wu J; Wiener JJ; Venkatesan H; Santillán A; Pippel DJ; Mani N; Morrow BJ; Motley ST; Shaw KJ; Wolin R; Grice CA; Jones TK
    Bioorg Med Chem Lett; 2007 May; 17(10):2723-7. PubMed ID: 17368897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and structure-activity relationship studies of ATP analogues as DNA gyrase inhibitors.
    Lübbers T; Angehrn P; Gmünder H; Herzig S; Kulhanek J
    Bioorg Med Chem Lett; 2000 Apr; 10(8):821-6. PubMed ID: 10782694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of potent Gram-negative specific LpxC inhibitors.
    Mansoor UF; Vitharana D; Reddy PA; Daubaras DL; McNicholas P; Orth P; Black T; Siddiqui MA
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1155-61. PubMed ID: 21273067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-ones as potential antimicrobial agents.
    Farghaly TA; Hassaneen HM
    Arch Pharm Res; 2013 May; 36(5):564-72. PubMed ID: 23446650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL
    Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC.
    Rose Y; Ciblat S; Reddy R; Belley AC; Dietrich E; Lehoux D; McKay GA; Poirier H; Far AR; Delorme D
    Bioorg Med Chem Lett; 2006 Feb; 16(4):891-6. PubMed ID: 16298129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations.
    Murphy-Benenato K; Wang H; McGuire HM; Davis HE; Gao N; Prince DB; Jahic H; Stokes SS; Boriack-Sjodin PA
    Bioorg Med Chem Lett; 2014 Jan; 24(1):360-6. PubMed ID: 24287382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of bacterial NAD⁺-dependent DNA ligase inhibitors: improvements in clearance of adenosine series.
    Stokes SS; Gowravaram M; Huynh H; Lu M; Mullen GB; Chen B; Albert R; O'Shea TJ; Rooney MT; Hu H; Newman JV; Mills SD
    Bioorg Med Chem Lett; 2012 Jan; 22(1):85-9. PubMed ID: 22154350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Suzuki K; Ito H; Kawasaki M; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2863-6. PubMed ID: 15125948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tethered dimers as NAD synthetase inhibitors with antibacterial activity.
    Velu SE; Cristofoli WA; Garcia GJ; Brouillette CG; Pierson MC; Luan CH; DeLucas LJ; Brouillette WJ
    J Med Chem; 2003 Jul; 46(15):3371-81. PubMed ID: 12852767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.